FYNOD (Alphapharm Pty Ltd)
Product name
FYNOD
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
159 (255 working days)
Active ingredients
Fingolimod hydrochloride
Registration type
New generic medicine
Indication
FYNOD is indicated for the treatment of adult and paediatric patients of 10 years of age and above with relapsing forms of multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.